Android app on Google Play

BofA/Merrill Lynch Upgrades Biogen (BIIB) to Buy

April 12, 2013 9:00 AM EDT Send to a Friend
Get Alerts BIIB Hot Sheet
Price: $336.39 --0%

Rating Summary:
    21 Buy, 7 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 16 | Down: 24 | New: 8
Trade BIIB Now!
Join SI Premium – FREE
BofA/Merrill Lynch upgraded Biogen (NASDAQ: BIIB) from Neutral to Buy with a price target of $246.00 (from $187.00).

For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.

Shares of Biogen closed at $200.26 yesterday.




You May Also Be Interested In


Related Categories

Hot Upgrades, Upgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment